INTRODUCTION

56"
Classically, T cells recognize peptide antigens when bound to major histocompatibility 57" complex (MHC) molecules (1). The six MHC class I and class II genes are among the most " 6"
Our data reveal a remarkable conservation of CD1B across diverse populations, which is
106"
in stark contrast to the polymorphism that is inherent in MHC. We hypothesized that this 107" structural constraint would enable a lipid-antigen specific T-cell response to be shared across 108" genetically unrelated members of a population. By analyzing the TCRs of T cells specific for a 109" mycobacterial lipid antigen, we identified a conserved T cell response that was detectable in the 110" blood of multiple unrelated individuals. Using TCR immunosequencing and flow cytometry, we
111"
show that this lipid-specific T cell population is expanded during tuberculosis infection and
112"
disease. Our data reveal one example of an antigen-specific shared T cell repertoire that could 113" be leveraged to develop molecular markers for diseases in which lipid antigens are targeted by 114" " 8"
Derivation of GMM-specific T cell lines from healthy South African donors
141"
The lack of allelic diversity within CD1B suggests that genetically unrelated individuals 142" might generate a shared T-cell response to a given lipid antigen. To test this hypothesis 143" directly, we used CD1B tetramers loaded with the immunodominant mycobacterial lipid glucose 144" monomycolate (GMM) to isolate antigen-specific T cells from four healthy South African adults.
145"
Tetramer-positive cells were expanded in-vitro for four weeks to derive GMM-specific T cell lines 146" (Figure 2A ). We confirmed that GMM-specific T cells were primarily CD4+, that they were 147" activated and produced IFN-γ in the presence of GMM and CD1b, and that they did not cross-
148"
react even with closely related antigens, such as mycolic acid ( Figure 2B and data not shown).
149"
Finally, we confirmed that GMM-specific T cell lines were functional, expressing IFN-γ, TNF-α,
150"
IL-2, IL-17, and CD40L when stimulated though cognate interactions with antigen or
151"
independently of the T-cell receptor ( Figure 2C and data not shown). These data confirm
152"
previously published data by our group and others showing that GMM-specific T cells with 153" similar functional profiles are present in the blood of unrelated donors (28, 29) .
154"
155"
The diversity of T cells that bind CD1B-GMM tetramer
156"
We then re-sorted those T cells that bound GMM-loaded CD1b tetramer with high avidity
157"
and exhaustively profiled the TCRs in both the tetramer-positive and tetramer-negative cell 158" populations using high-throughput immunosequencing (Figure 2A) 
166"
within the TCR-β chain sequences, in which tetramer-positive cells showed a clear bias towards 167" the use of certain variable and joining segments as compared to those observed in the tetramer-
168"
negative cells ( Figure 3B and Supplementary Figure 1 ). We then compiled lists of the most
169"
highly enriched V and J gene segments from TCR-α (TRAV1, TRAJ9) and  
170"
TRBJ2) by comparing expanded and resorted tetramer-positive cells to tetramer-negative cells
171"
and analyzing the length of the CDR3 region. We found that CDR3 length was severely
172"
restricted in these cell populations ( Figure 3C and Supplementary Figure 2 ). Collectively, these
173"
data provide further evidence of substantial restriction in the TCR-α and TCR-β chains that bind
174"
CD1B-GMM tetramers.
175"
176"
Unbiased definition of a shared GMM-specific TCR motif
177"
To determine whether there is a GMM-specific T-cell repertoire that is shared among
178"
unrelated donors, we standardized the analysis described above by constructing a simple test to
179"
identify TCR motifs. We defined motifs as sequences with common V and J family usage and
180"
CDR3 length that were significantly enriched in the expanded and re-sorted samples, as
181"
compared to their corresponding tetramer-negative samples. This unbiased approach resulted 182" in one TCR-α motif and one TCR-β motif that were significantly enriched independently in each
183"
of the four donors. The TCR-α motif contained a 13-amino acid CDR3 sequence that is
184"
consistent with the recently published TRAV01/TRAJ09 rearrangement present in GEM T cells
185"
( Figure 4A and Supplementary Table 1 ) (15). The TCR-β motif we discovered in this manner
186"
included a 14-amino acid CDR3 sequence that results from a TRBV06/TRBJ02 rearrangement
187"
( Figure 4B and Supplementary Table 1 ). Furthermore, several lines of evidence support co-
188"
expression of these motifs as a heterodimeric TCR in unrelated individuals. First, the dominant
189"
TCR-α and TCR-β sequences for one of our T cell lines analyzed in this study matches these 190" " 10"
motifs, suggesting they are co-expressed by a dominant T-cell clone (data not shown).
191"
Second, when we sorted GMM-CD1B tetramer avid cells from a fifth unrelated South African
192"
donor and performed limiting dilution to establish T-cell clones, we identified two T-cell clones
193"
whose TCRs match the TCR-α and TCR-β motifs described above ( Supplementary Table 2 ).
194"
Finally, Van Rhijn et al. reported a GMM-specific T-cell clone derived from an M.tb-infected
195"
subject whose TCR also matches these TCR-α and TCR-β motifs (15). Taken together, these
196"
data suggest that specific TCR-α and TCR-β chains that conform to the motif described above
197"
are co-expressed as a heterodimer, are specific for the mycobacterial antigen GMM, and are
198"
shared among multiple unrelated donors.
199"
200"
Predicted binding interactions and ontogeny of the GMM-specific TCR motifs
201"
We next addressed the question of how, given the stochastic nature of T-cell 202" development, these motifs might arise independently in unrelated donors. To accomplish this,
203"
we first assessed the enrichment of particular amino acid residues at each position along the
204"
CDR3 of expanded and re-sorted samples. In this analysis, we used tetramer-negative samples
205"
as a natural control and looked for differences in the CDR3 sequence of the motifs described
206"
above. In the TCR-α motif, we observed that the arginine at position 4 and leucine at position 5
207"
were enriched, suggesting that these residues are particularly important for mediating binding to
208"
the GMM-CD1B tetramer ( Figure 4C and Supplementary Tables 3 and 4 ). This inference is
209"
supported by TCR reconstitution experiments, in which a TCR containing a TCR-α chain that
210"
lacks arginine at position failed to respond functionally to GMM (15) . We also identified several
211"
enriched residues between positions 4 and 13 of the TCR-β motif ( Figure 4D and 212" Supplementary Table 4 ). Figure 4E shows the location of these enriched residue positions
213"
identified through sequence analysis mapped to the crystal structure of a GMM-specific TCR
214"
whose TCR-α and TCR-β chains match our motifs (15). Interestingly, both chains of the 215" " 11" heterodimer appear to contribute equally to binding the CD1B-GMM tetramer, which is
216"
supported by the recently published co-crystal of a GEM TCR with CD1B-GMM (30). These
217"
data highlight how immunosequencing can be used to infer structural requirements for antigen 218" binding by TCRs.
219"
We next explored the distribution of nucleotide additions and deletions leading to 220" junctional diversity in the TCR-α motif described above. We observed a lower level of 3'
221"
deletion in the V segment of TCR-α sequences from expanded and resorted T-cells than in the 222" those from tetramer-negative cells ( Figure 4F ). We note that the germline definition for TRAV01
223"
ends with CAVR ( Figure 4F ), which includes the conserved arginine at position 4 required for
224"
binding CD1B-GMM, suggesting that this CDR3 is germline-encoded, as previously proposed
225"
(15). In contrast, the germline sequence of TRAJ09 begins with GNTGGFKTIF, implying that
226"
position 5 of the selected motif results from selection of non-templated insertions that result in
227"
the encoding of a leucine residue in CD1B-GMM specific TCRs. Alternatively, it is possible that
228"
modulation of the residue distribution at position 5 could be a consequence of the restriction
229"
observed at position 4, since non-templated insertion has been shown to be context dependent
230"
(31). When we performed the same analysis for TCR-β, we observed an increased level of 3' V
231"
deletion in CD1B-GMM specific TCRs as compared to those observed in TCRs from tetramer-
232"
negative cells, suggesting that enriched residues at positions 4, 5, and 6 are likely non-
233"
templated. On the other hand, the enriched residues at positions 10 to 13 are located entirely
234"
within the germline-encoded TRBJ02 gene segment ( Figure 4G ). These data show that a
235"
GMM-specific shared TCR could arise through a combination of germline rearrangements and
236"
high-probability events occurring at junctions.
237"
238"
Ex-vivo analysis of GMM-specific TCR motifs in healthy donors 239" " 12" To extend the results described above, which were obtained from in-vitro expanded and
240"
resorted T-cell lines, we next examined sequences obtained from tetramer-positive cells sorted
241"
directly ex vivo (Figure 2A ). We pooled sequences from all four subjects studied initially and
242"
considered sequences concordant with the previously defined TCR-α and TCR-β motifs in terms 243" of V and J gene family and CDR3 length as matches ( Figure 4A and 4B ). We observed a 244" significant enrichment of both the TCR-α and TCR-β motifs among tetramer-positive cells as
245"
compared to tetramer-negative cells ( Table 1) . These data support the utility of the TCR motifs
246"
identified in this study as markers of antigen-specific T-cell responses ex vivo. We next
247"
examined the prevalence of the TCR-β motif in a previously published dataset that included
248"
TCR-β sequences obtained from the PBMC of 587 bone marrow donors at low risk for
249"
Mycobacterium tuberculosis infection (32). We found that the motif was present at a frequency 250" very similar to that observed in tetramer-negative T cells in the pooled data (Table 1 ). The
251"
relative absence of the GMM-specific TCR-β motif in T cells from healthy donors suggests that it
252"
could be used as a specific marker of mycobacterial infection in population-based studies.
253"
254"
GMM-specific TCR motifs during tuberculosis
255"
Finally, we investigated the association between GMM-specific TCR motifs and 256" mycobacterial infection by analyzing a cohort of South Africans with known M.tb infection status.
257"
This cohort included three clinical groups: adolescents without latent tuberculosis infection
258"
(IGRA-negative), adolescents with latent tuberculosis (IGRA-positive), and adults with a new
259"
diagnosis of active tuberculosis disease (Active TB, n=10). We comprehensively profiled the
260"
TCR-α and TCR-β chains from an average of approximately 100,000 T cells per donor by
261"
immunosequencing cryopreserved PBMCs, and we pooled the data into each of the three 262" clinical groups. Next, we calculated and compared the 'motif burden' of the TCR-α and TCR-β
263"
motifs described above, defined as the fraction of unique sequences that matched the V and J
264"
" 13" gene family, and CDR3 length of these motifs (Table 2) . For the TCR-α motif, we noted an
265"
increased motif burden in IGRA-positive subjects (p=0.0014) and active TB patients (p=8.3 x 10 -
266"
7 ) compared to IGRA-negative control subjects. For the TCR-β motif, we also observed an
267"
increased motif burden in IGRA-positive subjects (p=4.9 x 10 -5 ), and active TB patients (p=8.3 x 268" 10 -7 ) when compared to IGRA-negative subjects ( Table 2) . When we calculated subject-specific
269"
motif burdens, we confirmed enrichment in the TCR-α when comparing active TB patients to
270"
IGRA-negative subjects (p=0.004), although in this case we did not see an enrichment in the
271"
TCR-β motif burden ( Figure 5A and Supplementary Figure 3 ). Notably, we did not see
272"
enrichment of canonical MAIT cell or iNKT cell TCR-α rearrangements in active TB, highlighting
273"
the specificity of the association between a GMM-specific TCR-α motif and tuberculosis
274"
(Supplementary Figure 3) .
275"
We further validated these results using flow cytometry to quantify GMM-specific T cells
276"
ex vivo ( Supplementary Figure 4) . We found that the frequency of CD3 + T cells that stained
277"
with CD1B-GMM tetramer was higher in patients with active TB as compared to IGRA-negative
278"
control subjects (p=0.001, Figure 5B ). Finally, in one patient with active tuberculosis, we
279"
analyzed blood samples at diagnosis, during treatment, and at the completion of therapy, and
280"
we observed a decrease in the frequency of sequences that matched both the TCR-α and TCR-
281"
β motifs over time ( Supplementary Figure 3) . Together, these data support clonal expansion
282"
and contraction of GMM-specific T cells during mycobacterial infection and clearance,
283"
respectively, and demonstrate the association between GMM-specific TCR motifs and M.tb
284"
infection and disease.
285"
" 14"
DISCUSSION
286"
The phenomenon of MHC restriction has been a cardinal feature of T-cell immunology
287"
for more than forty years. In practical terms, this means that the ability to activate T cells
288"
depends not only on the foreign antigens they recognize, but also on the MHC molecules that 289" bind the antigen. By contrast, we show here that CD1B is nearly invariant among humans, and
290"
we report T-cell receptor motifs that are specific for a mycobacterial lipid antigen presented by
291"
CD1B, and consistently shared among multiple unrelated donors. We also show that T cells
292"
bearing these motifs are more frequent in South Africans with latent M.tb infection or
293"
tuberculosis disease than in M.tb-uninfected subjects. These data support the existence of a
294"
lipid antigen-specific shared T-cell repertoire that is independent of genetic background and
295"
could be leveraged to develop molecular diagnostics based on TCR sequence motifs.
296"
There are numerous examples of 'public' TCR sequences that are shared across 297" unrelated donors. Most of these have been reported as reactive to viral peptide antigens 298" (reviewed in (33) and (34)). However, these reports also make it clear that most T-cell
299"
responses are 'private' to a single individual, and that public T-cell responses are the exception 300" rather than the rule (7). Importantly, since most of these TCRs likely bind peptide-based 301" epitopes, they are by definition MHC-restricted. On the other hand, some T cells that share an
302"
invariant TCR-α chain, such as iNKT and MAIT cells, are widely prevalent but not clearly
303"
antigen-specific or related to pathogen exposure. In this study, we show that for CD1B
304"
presentation of GMM, a shared antigen-specific TCR response is seen reliably in more than 30 305" unrelated individuals. Our data support a model that requires a conserved, but not necessarily
306"
invariant, rearrangement in both α and β chains of the TCR heterodimer to recognize a foreign 307" lipid antigen. Additionally, by comparing the TCR sequences of GMM tetramer-positive and
308"
tetramer-negative T cells, we provide a structural rationale for this notion that is confirmed by
309"
the recent publication of GEM T cells and associated crystal structures (15, 30) . Our data 310" " 15" support the emerging paradigm that TCR recognition of foreign lipids follows a 'parallel docking
311"
mode' that is more reminiscent of peptide-MHC than of CD1d-αGalCer TCR interactions, which
312"
is relatively biased toward the TCR-α chain (35).
313"
Our unbiased approach to motif discovery is thus validated in the setting of GMM,
314"
suggesting it can be applied more broadly to lipid antigens outside of infectious diseases. For
315"
example, T cells have been described that recognize methyl-lyso phosphatidic acid when bound
316"
to CD1C expressed by acute myeloid and B cell leukemias (36). T cells recognizing
317"
lysophospholipids bound to CD1A contribute to pathogenic inflammation in atopic dermatitis and 318" psoriasis (37, 38). Human CD1A and CD1C tetramers as well as synthetic lipid antigens are
319"
available as validated reagents, so that an approach similar to the one described here could
320"
potentially be used to define allergic or cancer-specific shared TCRs and to test their clinical 321" associations.
322"
We detected GMM-specific TCR motifs in subjects without M.tb infection, suggesting
323"
either a high frequency of these motifs in the naïve T cell repertoire as a consequence of near-
324"
germline rearrangements, T-cell priming through mechanisms other than infection with M.
325"
tuberculosis, or both. Because GMM is produced by mycobacteria other than M.tb, this
326"
phenotype could result from exposure to non-tuberculous mycobacteria in the environment, or
327"
from vaccination with the M. bovis derived-BCG vaccine at birth, which is standard practice in
328"
South Africa. Consistent with this possibility, we found that the TCR-β motif was not enriched in
329"
a cohort of U.S. bone marrow donors who are at low risk for M.tb exposure and did not receive
330"
BCG. We can apply our unbiased approach to identify shared TCRs for lipids that are
331"
preferentially expressed by virulent M.tb. Unlike GMM, sulfoglycolipids are not expressed by
332"
BCG or most environmental bacteria, and T-cell responses to sulfoglycolipids have been shown
333"
to be greater in M.tb-infected subjects when compared to BCG-vaccinated subjects (39). The
334"
" 16" discovery of shared TCRs covering a variety of mycobacterial lipids could then be tested
335"
independently or in combination for utility as a molecular marker for tuberculosis.
336"
We used both immunosequencing and flow cytometry to demonstrate that GMM-specific
337"
T cells in peripheral blood are expanded during active tuberculosis. The increased abundance
338"
of the GMM-specific TCR motifs we identified among active TB patients suggests expansion of
339"
high-avidity clones in the presence of antigen. Moreover, we show a decrease in GMM-specific
340"
TCRs during treatment for active tuberculosis. These dynamic changes are consistent with the 341" development of immunologic memory to lipid antigens. By contrast, we show that the frequency
342"
of TCRs expressed by innate-like T cells, such as iNKT and MAIT cells, are not associated with 343" active tuberculosis. In this respect, GMM-specific T cells may more closely resemble
344"
conventional MHC-restricted T cells rather than innate-like T cells. Future studies could
345"
address whether these TCRs specific for mycobacterial lipids could be used as molecular
346"
markers of response to drug treatment or immunogenicity of whole cell vaccines, such as BCG.
347"
The advantage of maintaining a highly polymorphic pool of MHC genes in an outbred
348"
population have been extensively explored (40). In contrast, the advantages of maintaining a
349"
nearly invariant CD1B gene are less obvious. While MHC finds its origins in jawed vertebrates,
350"
CD1 genes have only been reported in mammals and birds, suggesting CD1 evolved from MHC
351"
genes to perform a non-redundant function. A number of pathogens have evolved mechanisms
352"
to avoid detection by the adaptive immune system, by varying the sequence of peptides
353"
available to bind host MHC molecules (41). Thus, CD1 may have evolved to facilitate T-cell
354"
detection of non-peptide antigens that are less likely to undergo mutational escape because of
355"
their importance in maintaining cell wall integrity. Supporting this notion is the success of
356"
mycolic acid synthesis inhibitors, such as isoniazid, for the treatment of tuberculosis. Isoniazid
357"
is predicted to also inhibit the production of GMM (42). Whether the findings we report here can
358"
be generalized to other lipids or non-peptide antigens remains to be determined, as do the true
359"
evolutionary origins of non-MHC systems of antigen presentation.
360"
"
17"
In summary, we provide evidence of purifying selection in human CD1B and identify a 361" set of conserved TCRs specific for CD1B and a mycobacterial lipid that is enriched during
362"
tuberculosis infection and disease. These data demonstrate a general framework for the rapid
363"
and unbiased identification of T cells specific for CD1-presented antigens as well as their
364"
associations with disease. These T cells are part of a potentially much larger shared T-cell
365"
repertoire that might have a number of potential clinical applications. One possibility is 366" molecular diagnosis of M.tb or any other disease characterized by lipid antigen-specific T-cells,
367"
such as atopic dermatitis, psoriasis, or leukemia. The other possibility is adoptive cell therapies
368"
that do not depend upon the genetic background of the patient. This is in contrast to current
369"
clinical trials of TCR-modified T cells, for example, that are typically limited to the dominant
370"
MHC haplotypes present in a population at risk for cancer (43). The realization of such novel
371"
cell therapies will require the identification of disease-specific lipid antigens and shared TCRs,
372"
but much of the technology for translating this information into a clinical therapy is already 373" available.
374"
" 18"
MATERIALS AND METHODS
375"
Generation of GMM-loaded CD1B tetramers.
376"
Soluble biotinylated CD1B monomers were provided by the National Institutes of Health
377"
Tetramer Core Facility (Emory University, Atlanta, GA). Glucose monomycolate (GMM)-loaded
378"
tetramers were generated as previously described (29). In brief, C32-GMM was dried down in a 379" glass tube using a nitrogen evaporator and sonicated into 0.25% CHAPS/sodium citrate at pH 4
380"
(preparation of CHAPS in sodium citrate; CHAPS Hydrate, Sigma; Sodium Citrate Dihdrate,
381"
Fisher) for two minutes at 37°C. The lipid solution was transferred to a microfuge tube, and 9
382"
µL of CD1B monomer was added. The CD1B-GMM preparation was then incubated in a 37°C
383"
water bath for 2 hours with vortexing every 30 minutes. At the end of the incubation, the
384"
solution was neutralized to pH 7.4 with 6 µL of 1M Tris pH 9. Finally, 10 µL of Streptavidin
385"
conjugated to allophycocyanin or phycoerythretin (Life Technologies) was added in ten aliquots
386"
of 1 µL every 10 minutes to facilitate tetramerization. The final product was filtered through a
387"
SpinX column (Sigma) to remove aggregates and stored at 4°C until use.
388"
389"
Antigens and Media
390"
C32-GMM purified from Rhodococcus equi was generously provided by the laboratory of D.
391"
Branch Moody (44). Our base T cell media consists of RPMI 1640 (Gibco) supplemented with
392"
100 U/mL Penicillin and 100 µg/mL Streptomycin (Gibco), 55 µM 2-mercaptoethanol (Gibco),
393"
0.3X Essential Amino Acids (Gibco), 60µM Non-essential Amino Acids (Gibco), 11mM HEPES
394"
(Gibco), and 800µM L-Glutamine (Gibco). We additionally supplemented this media with either
395"
fetal calf serum (HyClone) or human serum that was derived from healthy donors.
396"
397"
Generation of T cell lines using GMM-loaded CD1B tetramers 398" "
19"
Peripheral blood mononuclear cells (PBMC) were isolated from South African adults with latent 399" tuberculosis infection as defined by a positive QuantiFERON-TB Gold blood test. PBMC were 400" depleted of CD14-expressing monocytes for a separate study and cryopreserved. At the time of
401"
this study, PBMC were thawed and washed in warm RPMI 1640 (Gibco) supplemented with
402"
10% fetal calf serum (Hyclone) and 10 µL/mL Benzonase (Millipore) and enumerated using
403"
Trypan blue exclusion. PBMC were then plated in a 24-well plate at a density of three million 404" cells per well in T cell media and allowed to rest overnight at 37°C in humidified incubators
405"
supplemented with 5% CO 2 . The following day, PBMC were washed and blocked with 50%
406"
human serum (Valley Biomedical) in PBS supplemented with 0.2% BSA (Sigma) (FACS buffer)
407"
for 10 min at 4°C. The samples were washed twice with PBS and stained with Aqua Live/Dead
408"
stain (Life Technologies) according to the manufacturer's instructions. Following two additional
409"
PBS washes, cells were resuspended in 50 µL FACS buffer and 1 µL of either unloaded CD1B
410"
tetramer or GMM-loaded CD1B tetramer and incubated at room temperature for 40 minutes in 411" the dark. Finally, cells were stained with anti-CD3 ECD (Beckman Coulter) as well as surface
412"
markers for activation and memory phenotype, washed twice in T cell media, and screened
413"
through a cell strainer tube (Falcon) prior to sorting. Tetramer-positive T cells were sorted at the
414"
UW Department of Immunology Flow Cytometry Core using a FACS Aria II (BD) cell sorter
415"
equipped with 407nm, 488nm, and 641nm lasers.
416"
Sorted T cells were washed and resuspended in T cell media supplemented with 10%
417"
human serum. T cells were then divided among eight wells of a 96-well U-bottom tissue culture
418"
plate into which irradiated PBMC (150,000 cells per well) were added as feeder cells along with 419" phytohaemagglutinin (Remel) at a final concentration of 1.6 µg/ml. After two days in culture at 420" 37 o C, 5% CO 2 , 10 µL natural IL-2 (Hemagen) was added to each well. Half the media was
421"
replaced every two days with T cell media supplemented with 10% human serum and natural IL-
422"
2. When the cell clusters were large and round (approximately after eight days of growth), they 423" " 20"
were pooled into a 24-well plate. After 10 days in culture, cell lines were screened by tetramer
424"
staining or functional response to GMM. We then further expanded T cell lines by modifying a
425"
previously published rapid expansion protocol (45). Briefly, 200,000 T cells were mixed with 5
426"
million irradiated EBV-transformed B cells and 25 million irradiated PBMC as feeder cells in T 427" cell media. Anti-CD3 (clone OKT3) was added a final concentration of 30 ng/mL, and the
428"
mixture was incubated overnight at 37 o C, 5% CO 2 . The following day, recombinant IL-2 (rIL-2)
429"
(UWMC Clinical Pharmacy) was added to a final concentration of 50 U/mL. On day 4, the cells
430"
were washed twice in T cell media to remove OKT3, and fresh media supplemented with rIL-2
431"
at 50 U/mL was added. Half the media was replaced every three days or split into new T25
432"
tissue culture flasks (Costar) as determined by cell confluency. After 13 days in culture, the
433"
lines were screened by tetramer staining and then cryopreserved on day 14.
434"
435"
Clinical Cohorts
436"
As recently published, 6363 adolescents were enrolled into a study that aimed to
437"
determine the incidence and prevalence of tuberculosis infection and disease (46). Twelve to
438"
18 year-old adolescents were enrolled at eleven high schools in the Worcester region of the
439"
Western Cape of South Africa. Subjects were screened for the presence of latent tuberculosis
440"
by a tuberculin skin test and IFN-γ release assay (IGRA) QuantiFERON-TB GOLD In-Tube
441"
(Cellestis Inc.) at study entry. Peripheral blood mononuclear cells (PBMC) were isolated from 442" freshly collected heparinized blood via density centrifugation and cryopreserved. For this work,
443"
a subset of samples from 10 M.tb-infected and 10 M.tb-uninfected adolescents were selected 444" based on matching for age and sex and availability of cryopreserved specimens after
445"
completion of the primary objectives of the parent study. We also accessed a recently
446"
published cohort of South African adults with a new diagnosis of active tuberculosis (47). Only
447"
participants were included when ≥ 18 years of age and seronegative for HIV were included. All
448"
included patients had either positive sputum smear microscopy and/or positive culture for M.tb.
449"
21"
Blood was obtained and PBMC archived prior to or within 7 days of starting standard course
450"
anti-TB treatment, which was provided according to South African national health guidelines.
451"
For this work, a convenience sample from 10 adults with active tuberculosis was selected based
452"
on availability of cryopreserved specimens after completion of the primary study. For T-cell
453"
cloning studies, we used cryopreserved PBMC from a cohort of healthy South African adults
454"
(Supplemental Table 5 ).
455"
Human peripheral blood samples were also obtained from a cohort of healthy bone
456"
marrow donors from the Fred Hutchinson Cancer Research Center Research Cell Bank
457"
biorepository, under a protocol approved and supervised by the Fred Hutchinson Cancer
458"
Research Center Institutional Review Board, following written informed consent. This cohort has 459" been previously described (32) (Emerson et al., manuscript submitted).
460"
Flow Cytometry
461"
PBMC from South African adolescents and adults were thawed and rested overnight as 462" described above. The following day, one million PBMC per subject were counted and plated
463"
into each of two wells of a 96-well U-bottom plate. The cells were spun down and blocked in
464"
human serum and FACS buffer at 1:1 for ten minutes at 4°C. Following a wash with FACS
465"
buffer, the cells were resuspended in 50 µL FACS buffer, and 1 µL of either unloaded CD1B
466"
tetramer conjugated to PE or 1 µL GMM-loaded CD1B tetramer conjugated to APC. The
467"
samples were incubated at room temperature for 40 minutes and then washed twice with PBS.
468"
Aqua Live/Dead stain was then prepared at a 1:100 dilution in PBS and added to each sample.
469"
All samples were incubated for 15 min at room temperature in the dark. The samples were then
470"
washed twice and resuspended in 50 µL of staining cocktail containing anti-CD3 ECD in FACS
471"
buffer for 30 minutes at 4°C in the dark. Cells were then washed twice in FACS buffer and
472"
centrifuged at 1800 rpm for 3 min. All samples were then resuspended in 200 µL of 1% 
475"
476"
Functional Assays
477"
We used IFN-γ ELISPOT to examine antigen-specificity of T cell lines. Briefly, K562
478"
cells stably transfected with empty vector (K562-EV) or CD1B (K562-CD1B)(48) were
479"
maintained in RPMI 1640 (GIBCO) supplemented with 10% fetal calf serum and G418 (Sigma)
480"
at a concentration of 200 µg/ml and periodically assessed for CD1B expression by flow
481"
cytometry. Multiscreen-IP filter plates (Millipore) were coated with 1-D1K antibody (Mabtech)
482"
overnight at 4°C. Lipids were evaporated to dryness from chloroform-based solvents under a
483"
sterile nitrogen stream and then sonicated into media. This lipid suspension was added to co-
484"
cultures of 50,000 mock transfected or CD1B-transfected K562 antigen-presenting cells and
485"
2000 T cells with a final concentration of 1 µg/ml for MA and GMM (8, 49) . The co-cultures
486"
were incubated for 16 hours at 37°C. The following day, the cells were lysed with water and
487"
then incubated with 7-B6-1 biotin conjugate (Mabtech) for two hours at room temperature. The
488"
plate was washed with PBS (Life Technologies) and then incubated with ExtraAvidin-Alkaline
489"
Phosphatase (Sigma) for 1 hour at room temperature. Lastly, the wells were washed and then 490" developed using BCIP/NBT substrate (Sigma) for 5 min at room temperature in the dark. The
491"
wells were imaged and the IFN-γ spots were counted using an ImmunoSpot S6 Core Analyzer
492"
(Cellular Technology Limited).
493"
To observe intracellular cytokine staining following GMM antigen stimulation, 3.3 million
494"
K562 cells/ml were incubated with 5µg/mL GMM at a final volume of 100 µl for 18 hours at 495" 37 o C, 5% CO 2 to facilitate lipid loading. The following day, T cell lines were plated at 1 million
496"
cells/mL and 80µL of pre-loaded K562 cells was added to the T cells. The cell mixture was
497"
allowed to incubate for six hours in the presence of anti-CD28/49d antibodies (BD Biosciences),
498"
" 23"
Brefeldin A at a final concentration of 10 µg/ml (Sigma), and GolgiStop containing Monensin
499"
(BD), and anti-CD107a (BD) after which EDTA, at a final concentration of 2mM, was added to 500" disaggregate cells. Plates were stored at 4 o C until the following day when they were stained
501"
and acquired by FACS. We used a previously published optimized and validated 12-color panel 502" (50, 51) . Briefly, cells were first stained with Avid Live/Dead (Life Technologies) viability dye
503"
and anti-CD14. After washing, the cells were permeabilized with FACS Perm II (BD) and
504"
stained for the remaining markers (CD3, CD4, CD8, CD154, IFN-γ, TNF-α, IL-2, IL-4, IL-17a,
505"
and CD40L). Fully stained cells were washed and resuspended in 1% paraformaldehyde. Data
506"
were acquired on an LSR II (BD) equipped with a high-throughput sampler and configured with 507" 405nm (50mW), 488nm (20mW), 561nm (50mW), and 641nm (150mW) lasers.
508"
509"
Ethics 510"
The study was approved by the IRB of the University of Washington and the University
511"
of Cape Town. Written informed consent was obtained from all adult participants as well as
512"
from the parents and/or legal guardians of the adolescents who participated. In addition, written
513"
informed assent was obtained from the adolescents.
514"
515"
Comparative Genomics
516"
Data for CD1B (Chr1:158,327,951-158,331,531 ) and HLA-A (Chr6:29,941,260-
517"
29,945,884) were extracted from the 1000 Genomes Project (Phase 3; aligned to GRCh38), and
518"
measures of divergence calculated using VCFtools. Nucleotide diversity (π)
519"
(http://www.pnas.org/content/76/10/5269.abstract) was estimated with sliding windows of 50 520" 
525"
526"
Immunosequencing 527"
High-throughput sequencing of TCRs was performed using the ImmunoSEQ assay
528"
(Adaptive Biotechnologies) with TCR-β and/or TCR-α/δ assays for each sample using a 529" multiplex PCR approach following by Illumina high-throughput sequencing (52).
530"
531"
Putative CD1B-GMM specific TCR motifs defined by V/J gene usage and CDR3 length
532"
Sequence motifs for CD1B-GMM specific TCR-α and TCR-β were defined for each
533"
subject by assessing enrichment of specific V and J gene family usage and CDR3 lengths within
534"
the expanded and resorted sample as compared to the respective tetramer negative sample.
535"
For each possible combination of V family, J family, and CDR3 length, we enumerated unique
536"
sequences matching this combination, as well as the mismatching sequences for each sample.
537"
From these four counts (expanded/resorted, tetramer-negative, matching, and mismatching), we 538" generated a 2x2 contingency table and used Fisher's Exact test to assign a p-value for the
539"
significance of the enrichment of matches in the expanded and resorted sample. Such a test
540"
was performed for all combinations for each subject and for both TCR-α and TCR-β data, and
541"
we selected those with p-values below a pre-specified significance threshold (p < 0.001). This
542"
resulted in a set of CD1B-GMM specific TCR motifs for each subject. To define the 'public'
543"
CD1B-GMM specific TCR motifs within each locus, we identified motifs that were significantly 544" enriched as described above among all subjects.
545"
546"
Sequence conservation among CD1B-GMM specific TCRs matching putative motifs 547" "
25"
We determined the sequence conservation among putative motif matches of expanded
548"
and resorted TCRs (i.e. considered truly CD1B-GMM specific),s using putative motif matches
549"
among sequences derived from tetramer-negative cells as a natural control. For each possible
550"
amino acid at a given position in the CDR3, sequences matching the putative motif that
551"
contained this amino acid at the given position were enumerated for expanded and resorted
552"
data and tetramer-negative data, as were the sequences not matching that specific amino acid
553"
at the given position. From these four counts, we generated a 2x2 contingency table and used
554"
Fisher's Exact test to assign a p-value for significance of enrichment of this amino acid at the
555"
given position among the expanded and resorted putative motif matches. Such a test was
556"
performed for amino acids and CDR3 positions and for both TCR-α and TCR-β data, and we
557"
selected those with p-values below a pre-specified significance threshold (p-value < 0.001).
558"
Using the annotations of V, N, and J region boundaries (for TCR-α sequences) and V, N1, D,
559"
N2, and J region boundaries (for TCR-β sequences), we were also able to assess differences in
560"
recombination structure among CD1B-GMM specific TCRs with respect to nonspecific TCRs
561"
that also matched the putative motifs (53). By integrating these observations with the positions
562"
and identities of conserved residues, we were able to assess the conservation of germline-
563"
encoded sequence versus specific non-templated insertions.
564"
565"
CD1B-GMM specific TCR motif burden
566"
For population-level comparisons between T-cell populations or between patient groups,
567"
we defined the 'motif burden' of a sample simply as the fraction of unique TCRs from that
568"
sample that matched the CD1B-GMM specific TCR motif defined for the corresponding TCR-α
569"
or TCR-β. We first assessed significance by pooling all the sequences within each clinical group
570"
and counting the number that matched and the number that mismatched each motif using
571"
Fisher's exact test on the resulting contingency table. Pooling sequences from multiple donors
572"
" 26"
is sensitive to one donor with an excess of sequences biasing the result. To address this, we
573"
examined the sampling depth across donors in in each clinical group, and found that healthy
574"
subjects were not systematically undersampled (data not shown). We also assessed
575"
differences between clinical groups using subject-specific fractional motif burdens using the
576"
non-parametric Kruskall-Wallace test with Dunn post test (a generalization of the Mann-Whitney
577"
U test to more than two groups).
578"
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813!
We performed immunosequencing for each locus from IGRA-negative (n=10), IGRA-positive (n=10), and active TB (n=10) subjects,
814!
and then pooled the sequences for each locus from all subjects with a specific infection status. We tabulated the number of 815! sequences in the pool matching the defined CD1B-GMM specific TCR motif, as well as the complementary number of sequences not 816! matching the motif. Both IGRA-positive subjects and patients with active TB exhibit significant enrichment of both TCR-α and TCR-β 817! motifs as compared to IGRA-negative subjects. P-values were computed using Fisher's Exact test on the raw counts of matches and 818! mismatches. Because sampling depths varied widely among subjects, this pooling approach complements the subject-wise analysis 819! included in Fig. 5b , which eliminated sampling depth information by computing fractional motif burdens 820!
